CIK 0000907654
- Non-accelerated filer
- Smaller reporting company
Oruka Therapeutics, Inc.
Sign in to watch- Ticker
- ORKA
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 363855489
- Phone
- +1 650-606-7910
- Business address
- 855 OAK GROVE AVE., SUITE 100, MENLO PARK, CA, 94025
- Former names
- ARCA biopharma, Inc., NUVELO INC, HYSEQ INC
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market buy Director bought 10,000 shares at $4.16 ($41,630)
- 4 Open-market buy Director bought 5,000 shares at $4.28 ($21,400)
- 4 Open-market buy Director bought 3,056 shares at $4.66 ($14,241)
- 4 Open-market buy Director bought 10,000 shares at $4.77 ($47,660)
- 4 Open-market sale Chief Operating Officer sold 482 shares at $0.50 ($242)
- 4 Open-market sale VP, Finance sold 1,114 shares at $0.50 ($556)
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Derivatives Options or other derivatives
- 4 Open-market sale Chief Operating Officer sold 410 shares at $0.72 ($294)
- 4 Open-market sale VP, Finance sold 161 shares at $0.53 ($85)
- 4 Open-market sale 10% owner sold 1,541,331 shares at an average $0.55 ($846,905)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
- 4 Open-market sale 10% owner sold 1,460,209 shares at $0.50 ($731,273)
Page 8 of 23 · 459 filings